Market Access/ News/ News EMA backs emergency use of Lilly’s COVID antibodies Phil Taylor bamlanivimab, CHMP, coronavirus, COVID-19, Eli Lilly, ema, etesevimab, Regeneron 0 Comment The EMA’s human medicines committee has said two Eli Lilly antibodies are effective in people with COVID-19 who Share X EMA backs emergency use of Lilly’s COVID antibodies https://pharmaphorum.com/news/ema-backs-emergency-use-of-lillys-covid-antibodies/
bamlanivimab, CHMP, coronavirus, COVID-19, Eli Lilly, ema, etesevimab, Regeneron
0 Comment
